Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice. [electronic resource]
Producer: 20070508Description: 1080-6 p. digitalISSN:- 1524-4636
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Animals
- Antibodies, Anti-Idiotypic -- blood
- Aorta, Thoracic -- metabolism
- Aortic Diseases -- blood
- Apolipoproteins E -- deficiency
- Atherosclerosis -- blood
- Blood Pressure -- drug effects
- Disease Models, Animal
- Disease Progression
- Drosophila Proteins
- Enalapril -- pharmacology
- Follow-Up Studies
- Gene Expression -- drug effects
- Immunoglobulin G -- immunology
- Immunoglobulin M -- immunology
- Intercellular Adhesion Molecule-1 -- genetics
- Lipoproteins, LDL -- immunology
- Losartan -- pharmacology
- Mice
- Nephrectomy -- adverse effects
- Oxidation-Reduction
- Peptidyl-Dipeptidase A -- blood
- Prognosis
- RNA, Messenger -- genetics
- Receptors, Cell Surface
- Renin-Angiotensin System -- drug effects
- Uremia -- blood
- Vascular Cell Adhesion Molecule-1 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.